Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.84
+0.59 (11.24%)
May 18, 2026, 4:00 PM EDT - Market closed
Plus Therapeutics Employees
Plus Therapeutics had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$185,071
Profits / Employee
-$426,107
Market Cap
40.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 7 | 33.33% |
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Mereo BioPharma Group | 39 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Tevogen Bio Holdings | 18 |
| Quantum BioPharma | 17 |
| RenovoRx | 17 |
| Atossa Therapeutics | 16 |
| Nutriband | 13 |
PSTV News
- 3 days ago - Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c) - TheFly
- 3 days ago - Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout - GlobeNewsWire
- 3 days ago - Plus Therapeutics Earnings release: Q1 2026 - Filings
- 3 days ago - Plus Therapeutics Quarterly report: Q1 2026 - Filings
- 4 days ago - Plus Therapeutics Transcript: AGM 2026 - Transcripts
- 10 days ago - Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases - GlobeNewsWire
- 11 days ago - Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic - GlobeNewsWire
- 20 days ago - Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - GlobeNewsWire